NOV 29, 2016 1:59 PM PST

Eliminating Arrhythmia As A Diabetic Complication

WRITTEN BY: Kara Marker
Inflammation is healthy when it’s directed toward pathogenic infections, but it can also cause a dangerous complication of diabetes: heart arrhythmias. By identifying the “scene of the crime,” the point at which inflammation becomes dangerous, researchers can begin to prevent and treat arrhythmias as a diabetes-related disease.
Source: wiseGEEK
According to scientists from the the Federal University of Rio de Janeiro and their collaborators, well over half of all deaths related to diabetes stem from heart problems, most common being ventricular tachycardia. An increase in blood glucose, called hyperglycemia, in diabetics causes inflammation that specifically and directly affects the heart.

"It is noteworthy [to say] that inflammation is an important tool to fight infections, which usually ends when the 'intruder' is removed. In the case of diabetes, there is no infection,” said study coordinator, Professor Emiliano Medei. “Persistent hyperglycemia stimulates the immune system to produce a constant inflammation, with great production of IL-1-beta.”

Interleukin (IL)-1-beta is a cytokine, a chemical messenger in the immune system that is activated by macrophages and mediates the inflammatory response. Past research findings have linked IL-1-beta to inflammatory pain hypersensitivity.

Medei’s study focused on comparing two different groups of mice designed to be diabetic: wild-type or “normal” mice and mutant mice who weren’t capable of triggering IL-1-beta-associated inflammation. While both groups of mice showed increases in blood glucose as expected in a diabetes model, only the inflammatory mice - the wild-type group - experienced arrhythmias.

Even when under the influence of caffeine or dobutamine (drugs that promote ventricular tachycardia), the mutants who weren’t producing IL-1-beta were essentially protected from arrhythmias. As expected, scientists found IL-1-beta circulating in the hearts of wild-type diabetic mice. However, even for mice without diabetes or in isolated human heart cells, IL-1-beta on its own influenced heart function.

The solution? Two drugs that inhibit the IL-1-beta inflammatory process: MCC-950 and anakinra, which is already used to treat autoimmune diseases like rheumatoid arthritis. MCC-950 is first used to block IL-1-beta production from continuing, and then the existing IL-1-beta in the body system is stopped from affecting the body cells with anakinra.

“We found inflammation to be the link between arrhythmias and diabetes,” Medei explained. "I believe that the new therapeutic tools that we propose in this study are very promising to treat the heart disease caused by diabetes.”

Medei’s study was recently published in the journal Nature Communications.
 


Sources: D’or Institute For Research and Education, NCBI, American Diabetes Association
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 29, 2019
Immunology
OCT 29, 2019
Immune Protein Prevents Herpes Spreading to the Brain
An immune protein that was discovered more than two decades ago has been identified as the primary component of a molecular blockade that prevents genital
NOV 10, 2019
Drug Discovery & Development
NOV 10, 2019
Promising Results for New Vaccine Against Dengue Fever
Dengue fever is an illness transmitted by mosquito bites. Affecting around 390 million people per year, if left untreated, its mortality rate is 20%. Altho
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo
MAR 17, 2020
Immunology
MAR 17, 2020
What's the deal with SARS-CoV-2's spike protein?
Structurally, SARS-CoV-2 (the virus that causes COVID-19) are spherical shells consisting of a lipid membrane, with a core containing the virus’ gene
APR 06, 2020
Immunology
APR 06, 2020
Clearing the Path for Dendritic Cells to Eliminate Tumors
  Dendritic cells are the sentinels of the immune system and use their “tree-like” projections to present antigens from pathogens to initi
Loading Comments...